|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2001-12-28
|
|
pubmed:abstractText |
After the resolution of contrast enhancement, the majority of new MS lesions become isointense with surrounding white matter on T1-weighted MRI. Less commonly, a hypointense T1 lesion develops, representing the development of more severe focal tissue damage. Interferon beta (IFNbeta) reduces both the number of new enhancing lesions and the duration of contrast enhancement.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0028-3878
|
|
pubmed:author |
pubmed-author:BarkhofFF,
pubmed-author:BrexP APA,
pubmed-author:European Study Group on Interferon beta-1b in Secondary Progressive MS,
pubmed-author:FilippiMM,
pubmed-author:HahnDD,
pubmed-author:KapposLL,
pubmed-author:MillerD HDH,
pubmed-author:MolyneuxP DPD,
pubmed-author:PolmanC HCH,
pubmed-author:PozzilliCC,
pubmed-author:RollandYY,
pubmed-author:SalonenOO,
pubmed-author:SmiddyPP,
pubmed-author:ThompsonA JAJ,
pubmed-author:YousryT ATA
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
26
|
|
pubmed:volume |
57
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2185-90
|
|
pubmed:dateRevised |
2011-11-3
|
|
pubmed:meshHeading |
pubmed-meshheading:11756595-Adult,
pubmed-meshheading:11756595-Brain,
pubmed-meshheading:11756595-Double-Blind Method,
pubmed-meshheading:11756595-Female,
pubmed-meshheading:11756595-Follow-Up Studies,
pubmed-meshheading:11756595-Humans,
pubmed-meshheading:11756595-Interferon-beta,
pubmed-meshheading:11756595-Magnetic Resonance Imaging,
pubmed-meshheading:11756595-Male,
pubmed-meshheading:11756595-Middle Aged,
pubmed-meshheading:11756595-Multiple Sclerosis, Chronic Progressive
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
The effect of IFNbeta-1b on the evolution of enhancing lesions in secondary progressive MS.
|
|
pubmed:affiliation |
NMR Research Unit, Institute of Neurology, University College London, UK.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
